KD019 and Trastuzumab in Patients With Esophagus, Gastroesophageal Junction and Stomach Cancer

NCT02205463 · clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped IND application withdrawn

Conditions

Interventions

Sponsor

NYU Langone Health